bovin
monoclon
antibodi
pilu
antigen
e
coli
produc
murinebovin
hybridoma
vet
immunol
immunopathol
lymph
node
cell
calv
immun
purifi
pilu
antigen
enterotoxigen
e
coli
etec
fuse
mous
nweloma
nso
cell
nonlg
produc
mousecalf
hybridoma
bovin
igproduc
mousecalfcalf
secondari
hybridoma
line
secret
bovin
monoclon
igg
specif
pilu
antigen
elisa
obtain
case
th
two
line
deriv
xenohybridoma
fusion
partner
secret
bovin
monoclon
antibodi
one
year
continu
passag
none
antibodi
crossreact
pilu
type
includ
cfai
cfaii
cp
inhibit
agglutin
hors
rbc
receptor
presenc
ntigen
show
posit
fluoresc
indirect
bind
assay
etec
inhibit
adhes
piglet
enterocyt
antibodi
potenti
prophylact
therapeut
use
control
treatment
diarrhoea
one
caus
agent
neonat
diarrhoea
calv
farm
anim
noninvas
enterotoxigen
e
coli
call
fs
pilu
antigen
etec
smith
linggood
diseas
develop
gut
colon
bacteri
adher
enterocyt
thought
essenti
prevent
control
measur
date
includ
treatment
antibiot
kistwaria
misra
choudhuri
matern
vaccin
programm
acr
met
vari
success
anoth
treatment
dose
calv
antibodi
pilu
antigen
murin
monoclon
antibodi
use
purpos
sherman
acr
sadowski
springer
bray
raybould
muscoplat
altern
approach
investig
possibl
make
bovin
monoclon
antibodi
pilu
antigen
principl
homolog
antibodi
might
ultim
effect
heterolog
antibodi
addit
sinc
number
situat
veterinari
patholog
use
bovin
rather
murin
monoclon
antibodi
would
advantag
eg
studi
hostparasit
relationship
repeat
administr
antibodi
requir
present
investig
use
basi
explor
feasibl
make
bovin
monoclon
antibodi
gener
sinc
suitabl
bovin
myeloma
line
yet
avail
attempt
produc
bovin
monoclon
immunoglobulin
present
confin
use
interspecif
hybrid
made
fuse
mous
myeloma
cell
ljnnphocyt
immun
cattl
approach
met
success
goldsbi
tucker
dain
clark
donker
raybould
crouch
mcdougal
watt
howev
one
problem
interspecif
hybrid
xenohybridoma
like
somat
cell
hybrid
weiss
green
pontecorvo
lose
nonmurin
chromosom
divid
even
first
secret
immunoglobulin
usual
soon
lose
abil
preliminari
experi
babraham
indic
improv
stabil
could
achiev
use
murinebovin
xenohybridoma
primari
xenohybridoma
fusion
partner
first
grown
presenc
select
aminopterin
sensit
use
fusion
partner
lymphocyt
immun
calv
tucker
et
al
anderson
clark
stein
tucker
result
secondari
xenohybridoma
select
use
fusion
partner
produc
tertiari
xenohybridoma
present
paper
report
product
bovin
monoclon
antibodi
pilu
antigen
noninvas
enterotoxigen
e
coli
etec
use
fusion
refus
techniqu
pili
product
stimul
grow
ecoli
k
overnight
minca
medium
accord
method
guin
jansen
agterberg
presenc
subsequ
confirm
electron
microscopi
pilu
antigen
prepar
method
altmann
pylioti
mukkur
briefli
ecoli
heat
min
suspens
blend
bacteria
spun
pilu
protein
precipit
supernat
ph
use
acet
acid
precipit
taken
phosphat
buffer
salin
pb
ph
pilu
antigen
frequent
coexpress
bovin
etec
puriti
pilu
prepar
confirm
fact
sdspage
singl
band
appar
mw
k
obtain
wherea
antigen
mw
k
de
graaf
roorda
etec
agglutin
specif
slide
agglutin
test
antisera
etec
haemagglutin
guinea
pig
red
cell
presenc
mannos
de
graaf
roorda
one
month
old
steer
calf
inject
rump
ml
poplit
lymph
node
excis
calf
day
calf
day
follow
second
inject
fusion
partner
use
mous
myeloma
nso
cell
sublin
two
nonlg
secret
mousecalf
xenohybridoma
bovin
igglsecret
xenohybridoma
deriv
refus
tucker
et
al
poplit
lymph
node
chop
cultur
medium
use
small
scalpel
larg
lump
tissu
allow
settl
lymphocyt
suspens
pipet
centrifug
resuspend
cultur
medium
lymphocyt
fuse
nweloma
xenohybridoma
cell
ratio
respect
use
wv
polyethylen
glycol
rpmi
bdh
chemic
ltd
pool
uk
modif
method
describ
mcmaster
william
cell
cultur
plate
linbro
seed
x
cellsml
ml
per
well
select
medium
compos
rpmi
hypoxanthin
x
aminopterin
x
thymidin
flow
laboratori
irvin
scotland
plu
hors
serum
hs
describ
previous
tucker
et
al
control
well
unfus
fusion
partner
lymphocyt
set
case
cultur
supernat
remov
day
post
fusion
replac
fresh
medium
cell
clone
soft
agar
accord
method
describ
kshler
solid
phase
capturetyp
enzymelink
immunosorb
assay
elisa
use
detect
bovin
immunoglobulin
ig
present
cultur
supernat
flatbottom
plate
dynatech
uk
coat
overnight
dilut
bicarbon
buffer
ph
rabbit
antibodi
use
captur
antibodi
absorb
enterotoxigen
e
coli
etec
overnight
growth
longer
express
antigen
aft
mann
et
al
wash
plate
three
time
phosphat
buffer
salin
contain
tween
sigma
chemic
compani
ltd
pool
dorset
pbst
dilut
antigen
prepar
pbst
ad
hour
plate
wash
three
time
pbst
cultur
supernat
ad
incub
hour
three
wash
pbst
dilut
pbst
conjug
ad
left
anoth
hour
conjug
use
alkalin
phosphataseconjug
rabbit
antibodi
specif
bovin
heavi
light
ig
chain
jackson
immunoresearch
laboratori
avondal
pennsylvania
plate
wash
three
time
pbst
develop
use
pnitrophenyl
phosphat
sigma
diethanolamin
fison
plc
loughborough
uk
buffer
ph
mgml
optic
densiti
read
multiskan
automat
reader
nm
absorb
cultur
supernat
replac
pb
cultur
medium
neg
control
serum
taken
immun
calf
slaughter
use
posit
control
supernat
cell
line
deriv
fusion
use
xenohybridoma
test
antiforssman
activ
standard
haemolyt
test
sheep
red
blood
cell
describ
previous
tucker
et
al
immunoglobulin
precipit
cultur
supernat
use
volum
satur
ammonium
sulphat
method
jonak
describ
detail
previous
tucker
et
al
nso
origin
mous
myeloma
line
nonig
secret
primari
xenohybridoma
clone
secondari
xenohybridoma
deriv
refus
secret
bovin
igg
forssman
specif
fusion
partner
use
six
fusion
lymph
node
cell
two
steer
immun
pilu
antigen
tabl
fusion
distinct
hybridoma
coloni
visibl
cultur
plate
well
within
day
fusion
obviou
differ
fusion
mean
number
coloni
per
well
case
rel
low
number
coloni
probabl
underestim
mani
suspens
thu
make
count
difficult
tabl
show
percentag
posit
clone
obtain
line
assay
approxim
week
clone
clone
line
retain
antiforssman
activ
none
posit
hand
clone
isol
line
e
secret
one
clone
line
select
studi
lost
activ
month
cultur
clone
line
c
e
cultur
sever
week
reclon
clone
test
c
e
subclon
secret
antibodi
one
posit
subclon
c
e
maintain
secret
antibodi
one
year
continu
passag
elisa
antibodi
titr
clone
subclon
c
e
supernat
cell
densiti
x
assess
period
greater
equal
week
post
clone
subclon
titr
repres
ig
secret
rate
approxim
uglo
cellsml
year
continu
passag
titr
subclon
c
e
drop
metaphas
spread
xenohybridoma
show
presenc
bovin
chromosom
number
chromosom
cell
line
count
bovin
chromosom
distinguish
murin
clear
centromer
region
fig
number
bovin
chromosom
agre
previous
report
tucker
et
al
mxc
mxc
mxcxc
bovin
chromosom
clone
line
mxc
bovin
chromosom
count
month
fusion
featur
reclon
hybridoma
c
e
mxcxc
mxcxcxc
high
proport
polyploid
n
cell
line
c
bovin
chromosom
total
line
e
bovin
chromosom
total
total
concentr
supernat
line
c
e
shown
igg
isotyp
immunodiffus
test
class
confirm
autoradiographi
sd
page
gel
fusion
partner
nso
show
ig
chain
wherea
distinct
chain
faint
light
chain
differ
mw
appar
individu
light
heavi
chain
cultur
supernat
c
e
test
elisa
cfa
cfa
ii
cp
pilu
antigen
show
crossreact
cultur
supernat
line
c
e
inhibit
agglutin
hors
red
cell
etec
cultur
medium
alon
supernat
cultur
ceas
produc
antibodi
inhibit
agglutin
use
fitc
label
rabbit
antibovin
igg
second
antibodi
supernat
line
c
e
shown
bind
etec
control
sampl
show
fluoresc
supernat
line
c
e
inhibit
adhes
ztec
piglet
enterocyt
control
sampl
inhibit
fig
autoradiograph
sdspage
ig
chain
cultur
supernat
fusion
partner
nso
show
evid
ig
chain
secret
bd
wherea
show
chain
weak
light
chain
e
secret
line
e
show
evid
light
chain
secret
kl
control
includ
mous
monoclon
igg
respect
bovin
monoclon
igg
f
h
n
bovin
monoclon
igg
bovin
monoclon
igm
g
sbpernat
nonsecret
mousebovin
hybridoma
also
includ
j
preliminari
experi
murineovin
hybridoma
indic
use
xenohybridoma
might
offer
feasibl
approach
product
rumin
monoclon
antibodi
tucker
dain
wright
clark
first
report
product
monoclon
bovin
immunoglobulin
primari
xenohybridoma
srikumaran
et
al
srikumaran
et
al
howev
unknown
specif
raybould
et
al
use
techniqu
produc
bovin
monoclon
antibodi
bovin
enter
coronaviru
line
stabl
least
month
tucker
et
al
report
product
bovin
monoclon
antibodi
sheep
red
cell
antiforssman
use
xenohybridoma
fusion
partner
line
secret
antibodi
three
year
almost
continu
cultur
initi
reason
behind
use
xenohybridoma
rather
mous
myeloma
cell
fusion
partner
might
retain
bovin
chromosom
refus
therebi
increas
chanc
retain
chromosom
relev
ig
product
tucker
et
al
present
result
substanti
hypothesi
use
xenohybridoma
fusion
partner
result
stabl
line
increas
proport
bovin
mous
chromosom
bovin
chromosom
line
c
line
e
clone
line
deriv
nso
retain
bovin
chromosom
may
reason
particular
clone
abl
maintain
antibodi
secret
long
month
ceas
product
chromosom
analysi
line
carri
firm
conclus
drawn
involv
identif
individu
bovin
chromosom
earlier
result
use
xenohybridoma
indic
loci
ig
chain
product
may
chromosom
bovin
tucker
et
al
studi
line
may
help
confirm
assign
report
use
mous
x
human
hybridoma
fusion
partner
produc
human
monoclon
antibodi
conflict
result
teng
lam
piera
kaplan
ostberg
pusch
murphi
webb
earl
russ
churcher
tait
daspic
latter
show
failur
primari
mous
x
human
fusion
larg
due
higher
death
rate
xenohybrid
certainli
case
studi
primari
xenohybridoma
often
show
prolif
growth
mous
x
mous
hybridoma
murphi
et
al
also
found
secondari
xenohybrid
continu
surviv
although
ceas
immunoglobulin
synthesi
therefor
conclud
step
right
direct
toward
product
stabl
line
secret
human
monoclon
antibodi
anoth
factor
assess
stabil
hybridoma
line
number
time
necessari
reclon
raybould
et
al
clone
wherea
srikumaran
et
al
srikumaran
et
al
carri
three
earli
clone
gener
experi
xenohybridoma
advantag
clone
soon
possibl
posit
coloni
identifi
subsequ
clone
may
necessari
vari
clone
clone
subunit
composit
pilu
antigen
subject
much
debat
review
parri
rook
particular
question
rais
whether
haemagglutinin
adhesin
pilu
separ
subunit
fact
pilu
prepar
use
immunogen
present
studi
gave
singl
band
sdspage
approxim
mw
k
gave
rise
monoclon
antibodi
inhibit
adhes
haemagglutin
probabl
indic
molecul
pilu
antigen
involv
adhes
haemagglutin
ident
similar
monoclon
antibodi
provid
use
tool
studi
epitop
receptor
involv
etiolog
e
coli
infect
furthermor
product
homolog
monoclon
bovin
antiidiotyp
antibodi
becom
possibl
murinebovin
hybridoma
techniqu
describ
offer
consider
potenti
develop
monoclon
antibodi
relev
field
veterinari
scienc
date
use
techniqu
produc
line
secret
bovin
monoclon
antibodi
igg
igm
bovin
red
cell
alloantigen
tucker
mtnier
clark
well
bovin
pathogen
